Ken Griffin Drug Manufacturers—Specialty & Generic

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

Stock List

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.4B
$346 Million 0.06% of portfolio
2,538,109
Q4 2024 Added 43.84%
$78.3B
$178 Million 0.03% of portfolio
1,090,499
Q4 2024 New
$11.2B
$124 Million 0.02% of portfolio
9,956,809
Q4 2024 Added 135.78%
$1.31B
$71.1 Million 0.01% of portfolio
8,980,968
Q4 2024 Added 1.0%
$47B
$58.4 Million 0.01% of portfolio
6,105,593
Q4 2024 Added 406.87%
$18.3B
$52.6 Million 0.01% of portfolio
2,385,422
Q4 2024 Reduced 31.23%
$3.9B
$49 Million 0.01% of portfolio
1,904,384
Q4 2024 Reduced 39.65%
$2.69B
$41.9 Million 0.01% of portfolio
5,200,796
Q4 2024 Added 1.08%
$1.08B
$32.7 Million 0.01% of portfolio
591,594
Q4 2024 Added 11.65%
$5.3B
$19.5 Million 0.0% of portfolio
1,613,694
Q4 2024 Reduced 78.47%
$6.45B
$13.4 Million 0.0% of portfolio
149,410
Q4 2024 New
$991M
$10.1 Million 0.0% of portfolio
352,971
Q4 2024 Added 168.74%
$12.1B
$9.86 Million 0.0% of portfolio
118,021
Q4 2024 New
$401M
$6.32 Million 0.0% of portfolio
1,051,903
Q4 2024 Reduced 1.56%
$1.39B
$5.21 Million 0.0% of portfolio
140,413
Q4 2024 Added 3.83%
$760M
$3.98 Million 0.0% of portfolio
118,602
Q4 2024 Reduced 16.48%
$452M
$3.63 Million 0.0% of portfolio
2,730,871
Q4 2024 Added 47.51%
$1.72B
$3.41 Million 0.0% of portfolio
94,440
Q4 2024 Reduced 9.41%
$247M
$2.48 Million 0.0% of portfolio
560,464
Q4 2024 Reduced 19.64%
$781M
$2.02 Million 0.0% of portfolio
97,364
Q4 2024 Reduced 35.11%
$5.64B
$1.53 Million 0.0% of portfolio
53,206
Q4 2024 Reduced 35.84%
$373M
$1.44 Million 0.0% of portfolio
150,826
Q4 2024 Added 636.17%
$149M
$1.35 Million 0.0% of portfolio
381,678
Q4 2024 Reduced 56.22%
$4.22B
$1.12 Million 0.0% of portfolio
14,333
Q4 2024 Reduced 36.2%
$775M
$983,000 0.0% of portfolio
486,667
Q4 2024 Reduced 4.9%
$1.1B
$894,000 0.0% of portfolio
47,487
Q4 2024 Reduced 89.37%
$813M
$818,000 0.0% of portfolio
255,801
Q4 2024 Added 85.56%
$818M
$684,000 0.0% of portfolio
61,971
Q4 2024 Reduced 58.97%
$2.85B
$525,000 0.0% of portfolio
36,457
Q4 2024 Added 103.8%
$44.8B
$502,000 0.0% of portfolio
37,989
Q4 2024 New
$65.3M
$180,000 0.0% of portfolio
44,568
Q4 2024 New
$309M
$136,000 0.0% of portfolio
22,363
Q4 2024 Reduced 51.52%
$33.6M
$112,000 0.0% of portfolio
97,932
Q4 2024 New
$70.4M
$67,000 0.0% of portfolio
42,150
Q4 2024 Reduced 16.88%
$1.74B
$62,000 0.0% of portfolio
4,894
Q4 2024 Reduced 98.9%
$37.6M
$58,000 0.0% of portfolio
66,888
Q4 2024 New
$71.2M
$49,000 0.0% of portfolio
38,110
Q4 2024 Added 512.6%
$17.8M
$22,000 0.0% of portfolio
11,036
Q4 2024 Reduced 52.88%
$0
$6,000 0.0% of portfolio
41,431
Q4 2024 Reduced 8.2%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email